These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9548396

  • 21. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA, Schwartz MZ, Yoo EY, Mendelson KG, Duke DS.
    J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
    [Abstract] [Full Text] [Related]

  • 22. Deleted form of hepatocyte growth factor (dHGF) increases the number of platelets in rats with liver cirrhosis.
    Masunaga H, Fujise N, Yamashita Y, Shiota A, Yasuda H, Higashio K.
    Liver; 1997 Aug; 17(4):192-7. PubMed ID: 9298489
    [Abstract] [Full Text] [Related]

  • 23. Hepatocyte growth factor gene therapy of liver cirrhosis in rats.
    Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J.
    Nat Med; 1999 Feb; 5(2):226-30. PubMed ID: 9930873
    [Abstract] [Full Text] [Related]

  • 24. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression.
    Xu Q, Nakayama M, Suzuki Y, Sakai K, Nakamura T, Sakai Y, Matsumoto K.
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb 15; 302(4):G420-9. PubMed ID: 22159278
    [Abstract] [Full Text] [Related]

  • 25. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats.
    Masunaga H, Fujise N, Shiota A, Yamashita Y, Yasuda H, Higashio K.
    J Pharm Pharmacol; 1996 Aug 15; 48(8):876-9. PubMed ID: 8887742
    [Abstract] [Full Text] [Related]

  • 26. Hepatocyte growth factor promotes liver regeneration induced by transfusion of bone marrow mononuclear cells in a murine acute liver failure model.
    Jin SZ, Meng XW, Sun X, Han MZ, Liu BR, Wang XH, Pei FH.
    J Hepatobiliary Pancreat Sci; 2011 May 15; 18(3):397-405. PubMed ID: 21076985
    [Abstract] [Full Text] [Related]

  • 27. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.
    Tomiya T, Ogata I, Fujiwara K.
    Am J Pathol; 1998 Sep 15; 153(3):955-61. PubMed ID: 9736044
    [Abstract] [Full Text] [Related]

  • 28. Protective effect of theaflavin-enriched black tea extracts against dimethylnitrosamine-induced liver fibrosis in rats.
    Weerawatanakorn M, Lee YL, Tsai CY, Lai CS, Wan X, Ho CT, Li S, Pan MH.
    Food Funct; 2015 Jun 15; 6(6):1832-40. PubMed ID: 25927469
    [Abstract] [Full Text] [Related]

  • 29. Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats.
    Yamashita Y, Fujise N, Imai E, Masunaga H.
    Liver; 2002 Aug 15; 22(4):302-7. PubMed ID: 12296963
    [Abstract] [Full Text] [Related]

  • 30. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
    Song YN, Zhang GB, Lu YY, Chen QL, Yang L, Wang ZT, Liu P, Su SB.
    J Ethnopharmacol; 2016 Aug 02; 189():148-56. PubMed ID: 27196295
    [Abstract] [Full Text] [Related]

  • 31. A new amphiphilic derivative, N-{[4-(lactobionamido)methyl]benzylidene}-1,1-dimethyl-2-(octylsulfanyl)ethylamine N-oxide, has a protective effect against copper-induced fulminant hepatitis in Long-Evans Cinnamon rats at an extremely low concentration compared with its original form alpha-phenyl-N-(tert-butyl) nitrone.
    Asanuma T, Yasui H, Inanami O, Waki K, Takahashi M, Iizuka D, Uemura T, Durand G, Polidori A, Kon Y, Pucci B, Kuwabara M.
    Chem Biodivers; 2007 Sep 02; 4(9):2253-67. PubMed ID: 17886845
    [Abstract] [Full Text] [Related]

  • 32. Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis.
    Kaibori M, Inoue T, Sakakura Y, Oda M, Nagahama T, Kwon AH, Kamiyama Y, Miyazawa K, Okumura T.
    J Surg Res; 2002 Jul 02; 106(1):108-14. PubMed ID: 12127815
    [Abstract] [Full Text] [Related]

  • 33. Preventive effects of a fractioned polysaccharide from a traditional Chinese herbal medical formula (Yu Ping Feng San) on carbon tetrachloride-induced hepatic fibrosis.
    Wang JJ, Li J, Shi L, Lv XW, Cheng WM, Chen YY.
    J Pharm Pharmacol; 2010 Jul 02; 62(7):935-42. PubMed ID: 20636883
    [Abstract] [Full Text] [Related]

  • 34. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
    Takemura S, Azuma H, Osada-Oka M, Kubo S, Shibata T, Minamiyama Y.
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb 01; 314(2):G150-G163. PubMed ID: 28971836
    [Abstract] [Full Text] [Related]

  • 35. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension.
    Zhang ZT, Jiang P, Wang Y, Li JS, Xue JG, Zhou YZ, Yuan Z.
    Chin Med J (Engl); 2006 Oct 20; 119(20):1727-33. PubMed ID: 17097021
    [Abstract] [Full Text] [Related]

  • 36. Impaired hepatocyte regeneration in acute severe hepatic injury enhances effective repopulation by transplanted hepatocytes.
    Yu CH, Chen HL, Chen YH, Chang MF, Chien CS, Chang MH.
    Cell Transplant; 2009 Oct 20; 18(10):1081-92. PubMed ID: 19650970
    [Abstract] [Full Text] [Related]

  • 37. Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7.
    Pannem RR, Dorn C, Hellerbrand C, Massoumi R.
    Hepatology; 2014 Sep 20; 60(3):1066-81. PubMed ID: 24811579
    [Abstract] [Full Text] [Related]

  • 38. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
    Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, Sato N.
    J Hepatol; 2007 Feb 20; 46(2):286-94. PubMed ID: 17166617
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O.
    Am J Pathol; 2002 Feb 20; 160(2):613-20. PubMed ID: 11839582
    [Abstract] [Full Text] [Related]

  • 40. The protective role of hydrogen-rich saline in experimental liver injury in mice.
    Sun H, Chen L, Zhou W, Hu L, Li L, Tu Q, Chang Y, Liu Q, Sun X, Wu M, Wang H.
    J Hepatol; 2011 Mar 20; 54(3):471-80. PubMed ID: 21145612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.